CFRA Lifts Lincoln National Corp (LNC) Price Target as Q2 Results Impress
Lincoln National Corporation (NYSE:LNC) is one of the best mid-cap value stocks to buy right now.
Lincoln National Corp (LNC)
Market is closed
Sector: Life Insurance
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,150,321 | $39,801,107 | -19% | 0.03% |
| 2. | AQR Capital Management Cliff Asness | 1,054,109 | $36,472,179 | -49% | 0.03% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 952,700 | $32,963,420 | -40% | 0.07% |
| 4. | Alyeska Investment Group Anand Parekh | 895,156 | $30,972,398 | 0.11% | |
| 5. | Citadel Investment Group Ken Griffin | 874,265 | $30,249,569 | -48% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.90 | 10,000 | $259,000.00 | 10,000 | 2024-02-09 | Filing | |
| $25.52 | 7,838 | $200,025.35 | 15,007 | 2023-05-11 | Filing | |
| $27.90 | 7,169 | $200,002.99 | 7,169 | 2023-02-16 | Filing | |
| $37.41 | 3,000 | $112,230.00 | 4,000 | 2022-11-18 | Filing | |
| $35.96 | 3,000 | $107,880.00 | 3,000 | 2020-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.90 | 16,164 | $661,107.60 | 155,982 | 2025-08-15 | Filing | |
| $40.87 | 6,362 | $260,014.94 | 49,756 | 2025-08-15 | Filing | |
| $39.29 | 5,000 | $196,450.00 | 123,815 | 2025-08-07 | Filing | |
| $33.10 | 10,075 | $333,482.50 | 48,743 | 2025-05-29 | Filing | |
| $32.78 | 43,622 | $1,429,929.16 | 154,102 | 2025-05-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,719,786 | $647,704,596 | 0.01% | |
| 2. | 16,482,535 | $570,295,694 | 0.01% | |
| 3. | 6,199,526 | $214,503,600 | 0.01% | |
| 4. | 4,916,661 | $170,116,471 | 0.05% | |
| 5. | 4,645,447 | $160,732,468 | 0.13% |
News See All
12 Best Mid-Cap Value Stocks to Buy Right Now
Midcap stocks offer some of the best investment opportunities given their ability to strike the right balance between proven business deals and market opportunities that can support $100 billion corporations...
Lincoln National Corporation (NYSE:LNC) Q2 2025 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lincoln Financial's 2025 Second Quarter Earnings Call.
Lincoln National Corporation (LNC) Secures $825M Investment from Bain Capital
Lincoln National Corporation (NYSE:LNC), a leading U.S. provider of insurance and retirement solutions, is advancing its strategy in 2025 through a major partnership with Bain Capital.
11 Best Undervalued Stocks to Invest in Now
David Kostin, the Chief US Equity Strategist at Goldman Sachs Research, stated that in addition to the improved interest rate outlook, the Q1 2025 earnings results were strong, which increased confidence...
Jim Cramer Says “We're Not Going to Recommend” Lincoln National (LNC)
We recently published a list of 15 Stocks on Jim Cramer’s Radar.
15 Stocks on Jim Cramer’s Radar
On Thursday’s episode of Mad Money, host Jim Cramer turned his attention to the consumer packaged goods sector and expressed a clear sense of frustration and disappointment with how these stocks have...
Lincoln National Corporation (NYSE:LNC) Q1 2025 Earnings Call Transcript
Operator: Good morning, and thank you for joining Lincoln Financials' 2025 First Quarter Earnings Conference Call. At this time, all lines are in a listen only mode.
11 Ridiculously Cheap Stocks to Invest in
Just as we hunt for bargains in the commodity market-comparing relative prices, identifying discounted products, and getting the product most valued for our money—investing in the financial market isn...
10 Deep Value Stocks to Buy Now
Deep value investing is a more extreme form of value investing, focusing on stocks that are not just undervalued but significantly mispriced relative to their intrinsic worth.